首页> 美国卫生研究院文献>Lipids in Health and Disease >Increase of electronegative-LDL-fraction ratio and IDL-cholesterol in chronic kidney disease patients with hemodialysis treatment
【2h】

Increase of electronegative-LDL-fraction ratio and IDL-cholesterol in chronic kidney disease patients with hemodialysis treatment

机译:慢性肾脏病患者血液透析治疗中负电-LDL-分数比和IDL-胆固醇的升高

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundIt is known that the increased level of IDL and oxidized LDL are associated with risk of cardiovascular disease, and the lipoprotein abnormalities accelerate atherosclerosis. Cardiovascular disease is a major cause of mortality in chronic kidney disease patients with hemodialysis treatment (HD-Ps). Therefore, the estimation of lipoprotein profiles is important for prevention of cardiovascular disease in HD-Ps. We previously established an anion-exchange chromatographic method for measurement of cholesterol level in subclasses of HDL and LDL, IDL, VLDL, and chylomicron. An electronegative-LDL-fraction contained minimally oxidized-LDL. Lipoprotein profile can be accurately and conveniently determined by the new method.
机译:背景技术已知IDL和氧化的LDL水平升高与心血管疾病的风险有关,并且脂蛋白异常加速动脉粥样硬化。心血管疾病是接受血液透析治疗(HD-Ps)的慢性肾脏疾病患者死亡的主要原因。因此,脂蛋白谱的估计对于预防HD-Ps中的心血管疾病很重要。我们先前建立了一种阴离子交换色谱法,用于测量HDL和LDL,IDL,VLDL和乳糜微粒子类中的胆固醇水平。负电LDL馏分包含的氧化LDL最少。脂蛋白谱可以通过新方法准确,方便地确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号